The “next generation probiotics” are not available on the market yet, and consist of the microrganisms of the so-called “microbiota core“, the fundamental part of the microbiota.
Although research is making great progress in this area, several questions remain unanswered. Which bacterial species should be included in the “next generation probiotics”? What diseases will they help to treat? How will we obtain them? What will happen to current probiotics?
We discussed the “next generation” probiotics” with Prof. Antonio Gasbarrini, director of CEMAD at Gemelli Hospital in Rome.
